Application Nr Approved Date Route Status External Links
ANDA201779 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Zolmitriptan Tablets Are Indicated For The Acute Treatment Of Migraine With Or Without Aura In Adults. Limitations Of Use • Only Use Zolmitriptan Tablets If A Clear Diagnosis Of Migraine Has Been Established. If A Patient Has No Response To Zolmitriptan Tablets Treatment For The First Migraine Attack, Reconsider The Diagnosis Of Migraine Before Zolmitriptan Tablets Are Administered To Treat Any Subsequent Attacks. • Zolmitriptan Tablets Are Not Indicated For The Prevention Of Migraine Attacks. • Safety And Effectiveness Of Zolmitriptan Tablets Have Not Been Established For Cluster Headache. Zolmitriptan Tablets Are A Serotonin (5-Ht) 1b/1d Receptor Agonist (Triptan) Indicated For The Acute Treatment Of Migraine With Or Without Aura In Adults ( 1 ) Limitations Of Use : • Use Only After A Clear Diagnosis Of Migraine Has Been Established ( 1 ) • Not Indicated For The Prophylactic Therapy Of Migraine ( 1 ) • Not Indicated For The Treatment Of Cluster Headache ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Zolmitriptan ZOLMITRIPTAN ZINC15515

Comments